Kinase Outsourcing Leverage Cell Assay Innovations' ClariCELL platform to offer flexible, outsourced kinase cell-based assays to pharma, biotech, and CRO customers. Position the company as a fast-moving partner for screening and custom assay development that accelerates lead optimization and de-risks early programs.

Licensing Opportunities Explore licensing or co development arrangements to monetize the proprietary ClariCELL platform, expanding beyond services into product collaborations with pharmaceutical and biotech players.

Ideal Clients Target early stage biotech startups and academic labs needing assay development and screening, offering pilots and flexible engagement models to demonstrate value and establish long term partnerships.

Strategic Partnerships Develop channel partnerships with CROs, CMOs, and lab suppliers to extend reach and scale capabilities without a large internal headcount; emphasize joint go to market and bundled service offerings.

Value Proposition Differentiate with ClariCELL's cell-based kinase assays and integrated data interpretation services to help customers translate results into actionable decisions and clinical potential.